Climb Global Solutions Reports Fourth Quarter and Full Year 2023 Results
Q4 2023 Net Sales, Net Income, Adjusted EBITDA and EPS Increase to Record Levels FY 2023 Net Sales Increased 16% to […]
Trupanion to Participate in the Raymond James 2024 Institutional Investors Conference
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President, will present at the […]
Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial Results
RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced […]
Alkami Announces Fourth Quarter 2023 Financial Results
PLANO, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions […]
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
BOSTON and ATLANTA, Feb. 28, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical […]
MPA Delivery Partners Selected for Hudson Tunnel Project, The Most Urgent Infrastructure Project in the U.S.
CHANTILLY, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN), as part of the Mace-Parsons-Arcadis (MPA Delivery Partners) […]
Toll Brothers Announces New Luxury Home Community to Open Soon in Hopkinton, Massachusetts
HOPKINTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today […]
Green Thumb Industries Reports Fourth Quarter and Full Year 2023 Results
CHICAGO and VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) […]
TSX News -
Brompton Lifeco Split Corp. Announces Preferred Share Distribution Rate
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — (TSX: LCS, LCS.PR.A) Brompton Lifeco Split Corp. (the “Fund”) announces that the distribution […]
Arcutis and Sato Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan
Arcutis to receive a $25 million upfront payment, and is eligible to receive potential development and commercial milestone payments (totaling […]
